Filing Details
- Accession Number:
- 0001562180-25-005201
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-07-01 17:01:37
- Reporting Period:
- 2025-06-30
- Filing Date:
- 2025-07-01
- Accepted Time:
- 2025-07-01 17:01:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1517022 | Akebia Therapeutics Inc. | AKBA | Pharmaceutical Preparations (2834) | 208756903 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1762507 | Erik Ostrowski | C/O Akebia Therapeutics, Inc 245 First St. Cambridge MA 02142 | Svp, Cfo, Cbo & Treasurer | No | No | No | No |
Transaction Summary
| Sold: | 41,314 shares | Avg. Price: $3.67 | Total Value: $151,622.38 |
| Number of Shares After Transactions: | 503,586 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2025-06-30 | 41,314 | $3.67 | 503,586 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 21, 2024.
- This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on June 28, 2024.
Billionaire Hedge Funds
